DK0757669T3 - 0-Acyl-4-phenyl-cyclohexanoler, deres salte, lægemidler indeholdende disse forbindelser og deres anvendelse samt fremgangsm - Google Patents

0-Acyl-4-phenyl-cyclohexanoler, deres salte, lægemidler indeholdende disse forbindelser og deres anvendelse samt fremgangsm

Info

Publication number
DK0757669T3
DK0757669T3 DK94915531T DK94915531T DK0757669T3 DK 0757669 T3 DK0757669 T3 DK 0757669T3 DK 94915531 T DK94915531 T DK 94915531T DK 94915531 T DK94915531 T DK 94915531T DK 0757669 T3 DK0757669 T3 DK 0757669T3
Authority
DK
Denmark
Prior art keywords
denotes
pct
phenyl
acyl
compounds
Prior art date
Application number
DK94915531T
Other languages
English (en)
Inventor
Eberhard Woitun
Roland Maier
Ller Peter M
Rudolf Hurnaus
Michael Mark
Bernhard Eisele
Ralph-Michael Budzinski
Gerhard Hallermayer
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Application granted granted Critical
Publication of DK0757669T3 publication Critical patent/DK0757669T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/24—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups or amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)
DK94915531T 1992-11-20 1994-04-25 0-Acyl-4-phenyl-cyclohexanoler, deres salte, lægemidler indeholdende disse forbindelser og deres anvendelse samt fremgangsm DK0757669T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4239150A DE4239150A1 (de) 1992-11-20 1992-11-20 O-Acyl-4-phenyl-cyclohexanole, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung
BR9408573A BR9408573A (pt) 1992-11-20 1994-04-25 O-acil-4-fenil-ciclohexanóis seus sais medicamentos contendo estes compostos e seu uso bem como para sua preparação
PCT/EP1994/001276 WO1995029148A1 (de) 1992-11-20 1994-04-25 O-acyl-4-phenyl-cyclohexanole, deren salze, diese verbindungen enthaltende arzneimittel und deren verwendung sowie verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
DK0757669T3 true DK0757669T3 (da) 1999-08-02

Family

ID=27160120

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94915531T DK0757669T3 (da) 1992-11-20 1994-04-25 0-Acyl-4-phenyl-cyclohexanoler, deres salte, lægemidler indeholdende disse forbindelser og deres anvendelse samt fremgangsm

Country Status (17)

Country Link
US (1) US5726205A (da)
EP (1) EP0757669B1 (da)
JP (1) JPH09512255A (da)
AT (1) ATE173460T1 (da)
BG (1) BG62961B1 (da)
BR (1) BR9408573A (da)
DE (2) DE4239150A1 (da)
DK (1) DK0757669T3 (da)
ES (1) ES2126759T3 (da)
FI (1) FI964277A0 (da)
LV (1) LV11832B (da)
NO (1) NO307175B1 (da)
NZ (1) NZ266138A (da)
PL (1) PL179890B1 (da)
RU (1) RU2130921C1 (da)
SK (1) SK281213B6 (da)
WO (1) WO1995029148A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4239150A1 (de) * 1992-11-20 1994-05-26 Thomae Gmbh Dr K O-Acyl-4-phenyl-cyclohexanole, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung
DE19626771C2 (de) * 1996-07-03 1998-09-24 Merck Patent Gmbh 4-(4-Oxocyclohexyl)-benzamide
FR2754255B1 (fr) * 1996-10-08 1998-10-30 Synthelabo Procede de preparation de derives de trans-4-(4- aminomethylphenyl) cyclohexanols
DE19704401C1 (de) * 1997-02-06 1998-05-07 Thomae Gmbh Dr K Verfahren zur Herstellung von trans-4-(4-Aminomethyl)phenyl-cyclohexanolen
DE19754795A1 (de) * 1997-12-10 1999-06-17 Boehringer Ingelheim Pharma Neue Urethane, ihre Thio- und Dithioanaloga, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung
US20050107461A1 (en) * 2002-03-12 2005-05-19 Tian-Quan Cai Drug combination therapy
CA2710477A1 (en) 2007-12-20 2009-07-09 Envivo Pharmaceuticals, Inc. Tetrasubstituted benzenes
CA2877745C (en) 2012-07-04 2021-11-30 The University Of Sydney Treatment of inflammatory skin disorders
CA2946028C (en) 2014-04-16 2022-10-11 Zz Biotech Llc Treatment of abnormal cutaneous scarring

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431564A (en) * 1981-05-01 1984-02-14 Chisso Corporation Liquid-crystalline biphenyl or terphenyl derivatives
US5391571A (en) * 1989-11-15 1995-02-21 American Home Products Corporation Cholesterol ester hydrolase inhibitors
CA2044533A1 (en) * 1990-06-29 1991-12-30 Philippe Guerry Substituted aminoalkylbiphenyl derivatives
DE4239150A1 (de) * 1992-11-20 1994-05-26 Thomae Gmbh Dr K O-Acyl-4-phenyl-cyclohexanole, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung
DE4239151A1 (de) * 1992-11-20 1994-05-26 Thomae Gmbh Dr K N,N-Disubstituierte Arylcycloalkylamine, deren Salze, diese Verbindungen enthaltende Arzneimittel und deren Verwendung sowie Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
FI964277A (fi) 1996-10-24
BG62961B1 (bg) 2000-12-29
US5726205A (en) 1998-03-10
EP0757669B1 (de) 1998-11-18
LV11832A (lv) 1997-08-20
SK281213B6 (sk) 2001-01-18
WO1995029148A1 (de) 1995-11-02
PL179890B1 (pl) 2000-11-30
NO307175B1 (no) 2000-02-21
NO964525L (no) 1996-10-24
DE4239150A1 (de) 1994-05-26
PL316964A1 (en) 1997-03-03
NO964525D0 (no) 1996-10-24
ES2126759T3 (es) 1999-04-01
JPH09512255A (ja) 1997-12-09
NZ266138A (en) 1998-03-25
SK135996A3 (en) 1997-05-07
ATE173460T1 (de) 1998-12-15
FI964277A0 (fi) 1996-10-24
BR9408573A (pt) 1997-08-26
RU2130921C1 (ru) 1999-05-27
AU6721194A (en) 1995-11-16
DE59407317D1 (de) 1998-12-24
LV11832B (en) 1997-12-20
EP0757669A1 (de) 1997-02-12
BG100912A (en) 1997-07-31
AU685118B2 (en) 1998-01-15

Similar Documents

Publication Publication Date Title
ATE479667T1 (de) Als kinaseinhibitoren geeignete verbindungen auf thiazolylbasis
BG106073A (en) Quinoline derivatives as inhibitors of mek enzymes
MX9701765A (es) Derivado heterociclico y medicina.
DK0874812T3 (da) Hidtil ukendte 2,3,5-trimethyl-4-hydroxyanilidderivater, fremstilling deraf og terapeutisk anvendelse deraf
DK0757669T3 (da) 0-Acyl-4-phenyl-cyclohexanoler, deres salte, lægemidler indeholdende disse forbindelser og deres anvendelse samt fremgangsm
AU6970494A (en) New thiazolidindiones and drugs containing them
NO982901L (no) Nye barbitursyrederivater, fremgangsmåter for fremstilling av slike, samt farmasöytiske midler inneholdende disse forbindelser
MY133108A (en) Muscarinic antagonists
NO934196L (no) N,N-disubstituerte arylcykloalkylaminer, deres salter, legemidler inneholdende disse forbindelser, deres anvendelse og fremgangsmåte for deres fremstilling
DE69433148D1 (de) Tricyclische kondensierte heterocyclische Verbindungen zur Behandlung von seniler Demenz
NZ194528A (en) 4-phenoxypiperidines preparation and pharmaceutical compositions containing them
NO972938L (no) Farmasöytiske piperazinforbindelser
NO941516L (no) 3-kinolylsubstituerte dihydropyridiner, fremgangsmåter for deres fremstilling og deres anvendelse
ATE42747T1 (de) N-(2-(tetrahydro-3,5-dioxo-1h-pyrrolizin-7a(5h) yl)ethyl>aminderivate.
NO944332D0 (no) Substituerte pyridiner, samt fremstilling og farmasöytisk anvendelse derav
ATE278676T1 (de) Imdazol-derivate, deren herstellung und deren verwendung als s-adenosylmethionin decarboxylase (=samdc) inhibitoren
ES2174077T3 (es) Derivados de hidroxilamina antiisquemicos y composiciones farmaceuticas.
NO984547L (no) Nye oksazolidinderivater, fremgangsmÕte for deres fremstilling, samt legemidler inneholdende disse forbindelser
ATE111900T1 (de) 6-alkylpyridazinderivate, verfahren zu deren herstellung und diese enthaltende zusammensetzungen.
TH8799EX (th) การใช้อนุพันธ์ของอิมิแดโซพิแรโซลเป็นสารแก้ปวดและต่อต้านการอักเสบ
GEP19971013B (en) Novel pyridyl and pyrimidyl derivatives process for preparing thereof, and treatment method for mental disorder